Skip to Content

Investors

Company Profile

Altimmune is a clinical stage immunotherapeutics biotechnology company located in Montgomery County, MD with an additional operating site in London, UK. By leveraging the complementary attributes of its two innovative vaccine delivery platforms, RespirVec and Densigen, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including acute respiratory infections, chronic viral infections and cancer, with the potential for fundamental advantages over competing products.

Documents and Files
Vaxin Deal May Signal Maturation of Birmingham Biotech Industry
Source
Birmingham Business Journal -
What's on the Horizon for a Swine Flu Vaccine
Source
getbetterhealth.com -
Vaxin begins pandemic flu study using Birmingham volunteers
Source
The Birmingham News
Biotech firm Vaxin taps new CEO, looks for VC funds
Source
Birmingham Business Journal
Vaxin executives eye Taiwan for money, location incentives
Source
Birmingham Business Journal
(Taiwan) Vaxin's approach a 'new vision' for the vaccine industry: CEO
Source
Taiwan Life Sciences Weekly -

Company Profile

Altimmune is a clinical stage immunotherapeutics biotechnology company located in Montgomery County, MD with an additional operating site in London, UK. By leveraging the complementary attributes of its two innovative vaccine delivery platforms, RespirVec™ and Densigen™, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including acute respiratory infections, chronic viral infections and cancer, with the potential for fundamental advantages over competing products.

Featured Video

 

Investor Contact

Ashley Robinson
LifeSci Advisors, LLC
Email: ir@lifesciadvisors.com

View all

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Learn more